Relation between asymmetric dimethylarginine (ADMA) and hearing loss in patients with renal impairment

Renal Failure

Volumn 30, Issue 9, 2008, Pages 877-883

  Abdelwhab, Saeed ^a   Lotfy, Gamal ^b   Abdelmaksoud, Sahar ^a  

^a AIN SHAMS UNIVERSITY   (Egypt)

^b ZAGAZIG UNIVERSITY   (Egypt)

Author keywords

ADMA in CRF; Hearing in CRF; Pure tone audiometry in CRF; Renal impairment

Indexed keywords

CREATININE; N(G),N(G) DIMETHYLARGININE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONSERVATIVE TREATMENT; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; FEMALE; HEARING LOSS; HEMATOCRIT; HUMAN; KIDNEY DISEASE; MALE; PRIORITY JOURNAL; PURE TONE AUDIOMETRY; SMOKING;

ADULT; ARGININE; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CREATININE; FEMALE; HEARING LOSS, SENSORINEURAL; HUMANS; LIPIDS; MALE; MIDDLE AGED; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS;

EID: 54249167427     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.1080/08860220802356556     Document Type: Article

References (40)

1. Bergstrom L, Jenkins P, Sando I, G. E. and Hearing loss in renal disease. Clinical and Pathological Studies. Ann Oto Rhino Lary 1973;82:555-574.
2. Brookes GB. Vitamin D deficiency and deafness. Am J Otol. 1985;6:102-107.
3. Adler D, Fiehn W, Ritz E. Inhibition of Na+, K+-stimulated ATPase in the cochlea of the guinea pig. A potential cause of disturbed inner ear function in terminal renal failure. Acta Otolaryngol. 1980;90:55-60.
4. Orendorz-Fraczkowska K, Makulska I, Pospiech L, Zwolinska D. The influence of haemodialysis on hearing organ of children with chronic renal failure. Otolaryngol Pol. 2002;56:597-602.
5. Kakimoto Y, Akazawa S. Isolation and identification of N-G, N-G- and N-G,N′-G-dimethyl- arginine,N-epsilon-mono-, di-, and trimethyllysine, and glucosylgalactosyl- and galactosyl-delta-hydroxylysine from human urine. J Biol Chem. 1970;245:5751-5758.
6. Murray-Rust J, Leiper J, McAlister M, Phelan J, Tilley S, Santa Maria J. Structural insights into the hydrolysis of cellular nitric oxide synthase inhibitors by dimethylarginine dimethylaminohydrolase Nat Struct Biol. 2001;8:679-683.
7. Thum T, Tsikas D, Stein S, et al. Suppression of endothelial progenitor cells in human coronary artery disease by the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine. J Am Coll Cardiol. 2005;46:1693-1701.
8. Fliser D. Asymmetric dimethylarginine (ADMA): The silent transition from an 'uraemic toxin' to a global cardiovascular risk molecule. European Journal of Clinical Investigation. 2005;35:71-79.
9. Vallance P, Leone A, Calver A. Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet. 1992;339:572-575.
10. Ghiadoni L, Cupisti A, Huang Y. Endothelial dysfunction and oxidative stress in chronic renal failure. J Nephrol. 2004;17: 512-519.
11. Kielstein JT, Bode-Boeger SM, Hesse G, Martens-Lobenhoffer J, Fliser D, Hoeper MM. ADMA in idiopathic pulmonary arterial hypertension. Arterioscler Thromb Vasc Biol. 2005;25:570-574.
12. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499-502.
13. Macy EM, Hayes TE, Tracy RP. Variability in the measurement of C-reactive protein in healthy subjects: Implications for reference intervals and epidemiological applications. Clin Chem. 1997;43:52-58.
14. Chen BM, Xia LW, Zhao RQ. Determination of N(G),N(G)-dimethylarginine dimethylarginine in human plasma by high-performance liquid chromatography. J Chromatogr B Biomed Sci Appl. 1997;692:467-471.
15. Warady BA, Reed L, Murphy G, et al. Aminoglycoside ototoxicity in pediatric patients receiving long-term peritoneal dialysis. Pediatric Nephrol. 1993;7:178-181.
16. Zeigelboim B, Mangaberia-Albernaz P, Fukuda Y. High frequency audiometry and chronic renal failure. Acta Otolaryngol. 2001;121:245-248.
17. Gafter U, Shvili Y, Levi J, et al. Brainstem auditory evoked responses in chronic renal failure and the effect of hemodialysis. Nephron. 1989;53.
18. Mancini M, Dello Strologo L, Bianchi P, Tieri L, Rizzoni G. Sensorineural hearing loss in patients reaching chronic renal failure in childhood. Pediatr Nephrol. 1996;10:38-40.
19. Bains KS, Chopra H, Sandhu JS, Aulakh BS. Cochlear function in chronic kidney disease and renal transplantation: A longitudinal study. Transplant Proc. 2007;39:1465-1468.
20. Kusakari J, Kobayashi T, Rokugo M, et al. The inner ear dysfunction in hemodialysis patients. Nephrology Dialysis Transplantation. 1981;135:359-369.
21. Jorgenson MG. Changes in aging in the inner ear and the inner ear in diabetes mellitus. Histologic studies. Acta Otolaryngol. 1963;188:125-128.
22. Henrich W, Thompson P, Bergstrom L, Lum GM. Effect of dialysis on hearing acuity. Nephron. 1977;18:348-351.
23. Risvi SS, Holmes RA. Hearing loss from hemodialysis. Arch Otolaryngol. 1980;106:751-756.
24. deEspana R, Biurrun O, Lorente J, Traserra J. Hearing and diabetes. ORL J Otorhinolaryngol Relat Spec. 1995;57:325-327.
25. Diaz de Leon-Morales Luz V, Jauregui-Renaud K, Garay-Sevilla ME, Hernandez-Prado J, Malacara-Hemandez JM. Auditory Impairment in patients with type 2 diabetes mellitus. Archives of Medical Research. 2005;36:507-510.
26. Di Paolo B, Di Marco T, Cappelli P, et al. Electrophysiological aspects of nervous conduction in uremia. Clin Nephrol. 1988;29:253-260.
27. Hassan A, Hunt BJ, O'Sullivan M, et al. Markers of endothelial dysfunction in lacunar infarction and ischaemic leukoaraiosis. Brain. 2003;126:424-432.
28. Cooke JP, Rossitch E Jr, Andon NA, Loscalzo J, Dzau VJ. Flow activates an endothelial potassium channel to release an endogenous nitrovasodilator. J Clin Invest. 1991;88:1663-1671.
29. Ziegler EA, Hohlweg-Majert B, Maurer J, Mann WJ. Epidemiological data of patients with sudden hearing loss - a retrospective study over a period of three years. Laryngorhinootologie. 2003;82:4-8.
30. Mannini L, Cecchi E, Fatini C, et al. Clinical haemorheology and microcirculation. Ann Ist Super Sanità. 2007;43:144-155.
31. Charachon R, Moreno-Ribes V, Cordonnier D. Deafness due to renal failure. Clinicopathological study. Ann Otolaryngol Chir Cervicofac. 1978;95:179-203.
32. Zoccali C, Benedetto FA, Maas R, et al. Asymmetric dimethylarginine, C-reactive protein, and carotid intima-media thickness in end-stage renal disease. J Am Soc Nephrol. 2002; 13:490-496.
33. Markus C, Frantz A, Bertram F, Pontz B, Arnold W. Hyperbaric oxygen treatment restores sudden hearing loss in a patient with Fabry disease. ORL J Otorhinolaryngol Relat Spec. 2008;70:210-213.
34. Kielstein JT, Donnerstag F, Gasper S, et al. ADMA increases arterial stiffness and decreases cerebral blood flow in humans. Stroke. 2006;37:2024-2029.
35. Antonelli A, Bonfiolii F, Garrubbaa V, et al. Audiological findings in elderly patients with chronic renal failure. Acta Otolaryngologica. 1991;476:54-68.
36. Chan NN, Vallance P. Hyperhomocysteinaemia and neuropathy in Type 2 diabetes. Diabetic Medicine. 2001;18:1008-1009.
37. Thodi C, Thodis E, Danielides V, Pasadakis P, Vargemezis V. Hearing in renal failure. Nephrol Dial Transplant. 2006;21:3023-3030.
38. Kielstein JT, Fliser D. The past, presence and future of ADMA in nephrology. Néphrologie & Thérapeutique. 2007;3:47-54.
39. Saran R, Novak JE, Desai A, et al. Impact of vitamin E on plasma asymmetric dimethylarginine (ADMA) in chronic kidney disease (CKD): A pilot study. Nephrol Dial Transplant. 2003;18:2415-2420.
40. Hu T, Chouinard M, Cox AL, et al. FXR agonist reduces serum asymmetric dimethylarginine levels through hepatic dimethylarginine dimethylaminohydrolase- 1 gene regulation. J Biol Chem. 2006;281:39831-39838.